Kymera Therapeutics, Inc. (KYMR) earnings date

Nasdaq · Large cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 38 days, typically, give or take 11 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Oct 29, 2026before open 29 8-K
Q2 FY2026Wed, Aug 5, 2026before open 36 8-K
Q1 FY2026Thu, Apr 30, 2026before open 30 8-K
Q4 FY2025Thu, Feb 26, 2026before open 57 8-K
Q3 FY2025Tue, Nov 4, 2025before open 35 8-K
Q2 FY2025Mon, Aug 11, 2025before open 42 8-K
Q1 FY2025Fri, May 9, 2025before open 39 8-K
Q4 FY2024Thu, Feb 27, 2025before open 58 8-K

What they guided beta

Q3 FY2026 "Kymera Therapeutics Announces Third Quarter 2026 Financial Results and Reports Positive Results from the KT-579 Phase 1 Healthy Volunteer Trial KT-579 (IRF5) Phase 1 healthy volunteer data demonstrated deep, sustained IRF5 degradation, robust modulation of disease-relevant biomarkers and a favorable safety profile KT-579 LUMORA Phase 1b trial in lupus patients planned to start by early 2027 Last patient completed last visit in KT-621 (STAT6) BROADEN2 Phase 2b AD trial, with topline data to be reported by year-end 2026 KT-621 BREADTH Phase 2b asthma trial ongoing, with topline data expected" exhibit
Q3 FY2026 "Subject to discussions with regulators, the Company expects to initiate the first Phase 3 trial in AD by mid-2027." exhibit
Q3 FY2026 "Enrollment is ongoing in the KT-621 BREADTH Phase 2b clinical trial in patients with moderate to severe eosinophilic asthma, with topline data expected to be reported in late 2027." exhibit
Q3 FY2026 "The Company does not expect to recognize additional collaboration revenue in 2026." exhibit
Q3 FY2026 "Kymera expects that its cash balance will provide the Company with a cash runway into 2029 beyond multiple clinical inflection points in its pipeline." exhibit
Q2 FY2026 "Enrollment completed in KT-621 (STAT6) BROADEN2 Phase 2b AD trial nearly six months ahead of anticipated timeline, with data expected by year-end 2026 KT-621 Phase 3 trials in AD planned to initiate by mid-2027 KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to be reported in late 2027 KT-579 (IRF5) Phase 1 healthy volunteer trial ongoing, with data expected in 4Q26" exhibit
Q2 FY2026 "The accelerated timeline enables us to pull forward our expected topline readout to year-end 2026, positions us for an earlier than anticipated start to Phase 3 trials next year, and ultimately allows us to move faster for patients who are waiting for new options.”" exhibit
Q2 FY2026 "The earlier than expected completion of enrollment enabled the Company to accelerate its expected topline data readout by six months to year-end 2026, earlier than prior guidance to share data by mid-2027." exhibit
Q2 FY2026 "Subject to discussions with regulators, the Company expects to initiate Phase 3 trials in AD by mid-2027." exhibit
Q2 FY2026 "The Company expects to report data in late 2027." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/KYMR
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/KYMR

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

KYMR earnings date badge

HTML

<a href="https://veritasdata.dev/company/KYMR/"><img src="https://veritasdata.dev/embed/KYMR.svg" alt="KYMR earnings date" width="240" height="56"></a>

Markdown

[![KYMR earnings date](https://veritasdata.dev/embed/KYMR.svg)](https://veritasdata.dev/company/KYMR/)

Script

<script async src="https://veritasdata.dev/embed/KYMR.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/KYMR"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.